These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16048592)

  • 21. Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy.
    Truong U; Moon-Grady AJ; Butani L
    Pediatr Transplant; 2005 Aug; 9(4):541-4. PubMed ID: 16048611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation.
    Weintraub L; Li L; Kambham N; Alexander S; Concepcion W; Miller K; Wong C; Salvatierra O; Sarwal M
    Pediatr Transplant; 2008 Aug; 12(5):541-9. PubMed ID: 18564305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.
    Valentini RP; Imam A; Warrier I; Ellis D; Ritchey AK; Ravindranath Y; Shapiro R; Moritz ML
    Pediatr Transplant; 2006 May; 10(3):358-61. PubMed ID: 16677361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin--rather than FK506--might promote allograft tolerance induced by CD4+CD25+ regulatory T cells.
    Du JF; Li SY; Yu B
    Surgery; 2009 Sep; 146(3):526-7; author reply 527-8. PubMed ID: 19715817
    [No Abstract]   [Full Text] [Related]  

  • 26. [Everolimus].
    Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2263-5. PubMed ID: 16208601
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
    Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
    Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
    Savikko J; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2699-700. PubMed ID: 17098043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rapamycin and lymphangiogenesis: side effect or treatment result?].
    Stallone G
    G Ital Nefrol; 2008; 25(2):157. PubMed ID: 18350493
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells.
    Krocker D; Perka C; Tuischer J; Funk J; Tohtz S; Buttgereit F; Matziolis G
    Transpl Int; 2006 Jul; 19(7):563-9. PubMed ID: 16764635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
    Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
    Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirolimus in de novo heart transplant recipients with severe renal impairment.
    Vazquez de Prada JA; Vilchez FG; Cobo M; Ruisanchez C; Valls MF; Ruano J; Piñera C; Duran RM
    Transpl Int; 2006 Mar; 19(3):245-8. PubMed ID: 16441775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent clinical impact of cytomegalovirus in organ transplantation.
    Snydman DR
    Clin Infect Dis; 2008 Oct; 47(7):883-4. PubMed ID: 18778227
    [No Abstract]   [Full Text] [Related]  

  • 34. [To stay immature: the first step to tolerate?].
    Grosjean F
    G Ital Nefrol; 2008; 25(4):383. PubMed ID: 18663680
    [No Abstract]   [Full Text] [Related]  

  • 35. Conversion to sirolimus in posttransplant renal neoplasms.
    Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M
    Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
    Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schäfer H; Detter C; Reichenspurner H
    Transpl Int; 2006 Apr; 19(4):310-8. PubMed ID: 16573547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy after solid organ transplantation.
    Mastrobattista JM; Gomez-Lobo V;
    Obstet Gynecol; 2008 Oct; 112(4):919-32. PubMed ID: 18827137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Krüger B; Fischereder M; Jauch KW; Graeb C; Hoffmann U; Böger CA; Banas B; Obed A; Schlitt HJ; Krämer BK
    Transplant Proc; 2007 Mar; 39(2):518-21. PubMed ID: 17362772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapamycin (sirolimus): a two-edged sword?
    J Gross G
    J Mol Cell Cardiol; 2006 Aug; 41(2):226-7. PubMed ID: 16781729
    [No Abstract]   [Full Text] [Related]  

  • 40. Sirolimus in chronic allograft nephropathy in pediatric recipients.
    Ibáñez JP; Monteverde ML; Diaz MA; Goldberg J; Turconi AF
    Pediatr Transplant; 2007 Nov; 11(7):777-80. PubMed ID: 17910656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.